HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 539/2/579    most recent 2001.013473v1 Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Egan, C. G. Articles by McLean, J. S. Search for Related Content PubMed PubMed Citation Articles by Egan, C. G. Articles by McLean, J. S.

Pathophysiological basis of acute inflammatory hyperaemia in the rat knee: roles of cyclo-oxygenase-1 and -2

Colin G. Egan, John C. Lockhart, William R. Ferrell*, Suzanne M. Day and John S. McLean

The role of different isoforms of cyclo-oxygenase (COX) in mediating the acute (0-6 h) and late (24 h) phases of inflammation was investigated in the rat knee joint following intra-articular injection of carrageenan. The hyperaemic response was assessed transcutaneously using laser Doppler imaging (LDI). Samples were taken at corresponding time points for detection of synovial COX-1, COX-2 and inducible nitric oxide synthase (iNOS) mRNA, and measurement of urinary prostaglandin (PG) and nitric oxide metabolites (NO_x). A non-selective COX inhibitor (indomethacin, 15 mg kg^-1 I.P.), a selective COX-2 inhibitor (SC-236, 16.8 mg kg^-1 I.P.) or vehicle were administered 1 h prior to carrageenan in the acute phase study. LDI scans were taken hourly for 4 h post-induction. Inflammatory hyperaemia in the vehicle group was attenuated in the indomethacin- (P < 0.001, two-way ANOVA) and SC-236-treated groups (P < 0.0001), with no difference between these treatments. At 24 h, I.V. infusion of indomethacin (0.1 mg min^-1), increased vascular resistance (24 ± 7.1 %; P < 0.05) compared to vehicle infusion, whereas SC-236 (0.11 mg min^-1) did not. Resistance changes to indomethacin also differed from SC-236 (P < 0.05). Knee joint diameter progressively increased over 24 h (P < 0.0001, one-way ANOVA). Urinary PG levels increased by 6 h (P < 0.05), but returned to baseline by 24 h. COX-1 mRNA was detectable at all time points; COX-2 mRNA only at 3 h. Urinary NO_x levels increased progressively over 24 h (P < 0.05), paralleled by induction of iNOS in the 3 and 24 h samples. Prostaglandin production via COX-2 appears to mediate the development of acute inflammatory hyperaemia, but nitrergic mechanisms may supervene subsequently. COX-1 but not COX-2 contributes to the maintenance of basal blood flow in the hyperaemic joint at 24 h.

This article has been cited by other articles:

				N. L. Chillingworth, S. G. Morham, and L. F. Donaldson Sex differences in inflammation and inflammatory pain in cyclooxygenase-deficient mice Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R327 - R334. [Abstract] [Full Text] [PDF]

				S M Day, J C Lockhart, W R Ferrell, and J S McLean Divergent roles of nitrergic and prostanoid pathways in chronic joint inflammation Ann Rheum Dis, December 1, 2004; 63(12): 1564 - 1570. [Abstract] [Full Text] [PDF]

				C. G. Egan, J. C. Lockhart, and W. R. Ferrell Pathophysiology of vascular dysfunction in a rat model of chronic joint inflammation J. Physiol., June 1, 2004; 557(2): 635 - 643. [Abstract] [Full Text] [PDF]